Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 9
Submit an article Journal homepage
1,749
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells

Todd A. BraciakDepartment of Hematology and Oncology, Medizinische Klinik und Poliklinik III, Klinikum der Universität München, Munich, GermanyView further author information
,
Claudia C. RoskopfDepartment of Hematology and Oncology, Medizinische Klinik und Poliklinik III, Klinikum der Universität München, Munich, GermanyView further author information
,
Sarah WildenhainDepartment of Biochemistry and Gene Center, Ludwig-Maximilians-Universität, Munich, GermanyView further author information
,
Nadja C. FennDepartment of Biochemistry and Gene Center, Ludwig-Maximilians-Universität, Munich, GermanyView further author information
,
Christian B. SchillerDepartment of Biochemistry and Gene Center, Ludwig-Maximilians-Universität, Munich, GermanyView further author information
,
Ingo A. SchubertDepartment of Biology, University of Erlangen-Nuremberg, Erlangen, GermanyView further author information
,
Uwe JacobWestend Innovation, Munich, GermanyView further author information
,
Annemarie HoneggerDepartment of Biochemistry, University of Zurich, Zurich, SwitzerlandORCID Iconhttp://orcid.org/0000-0002-3378-3967View further author information
ORCID Icon,
Christina KrupkaDepartment of Hematology and Oncology, Medizinische Klinik und Poliklinik III, Klinikum der Universität München, Munich, Germany;Laboratory of Translational Cancer Immunol ogy, Gene Center of the LMU Munich, Munich, GermanyView further author information
,
Marion SubkleweDepartment of Hematology and Oncology, Medizinische Klinik und Poliklinik III, Klinikum der Universität München, Munich, Germany;Laboratory of Translational Cancer Immunol ogy, Gene Center of the LMU Munich, Munich, GermanyView further author information
,
Karsten SpiekermannDepartment of Hematology and Oncology, Medizinische Klinik und Poliklinik III, Klinikum der Universität München, Munich, GermanyView further author information
,
Karl-Peter HopfnerDepartment of Biochemistry and Gene Center, Ludwig-Maximilians-Universität, Munich, GermanyView further author information
,
Georg H. FeyDepartment of Biology, University of Erlangen-Nuremberg, Erlangen, GermanyView further author information
,
Michael AignerDepartment of Internal Medicine 5 - Hematology/Oncology, University of Erlangen-Nuremberg, Erlangen, GermanyView further author information
,
Stefan KrauseDepartment of Internal Medicine 5 - Hematology/Oncology, University of Erlangen-Nuremberg, Erlangen, GermanyView further author information
,
Andreas MackensenDepartment of Internal Medicine 5 - Hematology/Oncology, University of Erlangen-Nuremberg, Erlangen, GermanyView further author information
&
Fuat S. OduncuDepartment of Hematology and Oncology, Medizinische Klinik und Poliklinik III, Klinikum der Universität München, Munich, GermanyCorrespondence[email protected]
View further author information
 show all
Article: e1472195 | Received 20 Feb 2018, Accepted 29 Apr 2018, Published online: 30 Jul 2018

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.